Biltmore Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,911
Closed -$614K 48
2020
Q4
$614K Sell
1,911
-119
-6% -$36.5K 0.32% 21
2020
Q3
$534K Sell
2,030
-129
-6% -$34.7K 0.31% 21
2020
Q2
$490K Sell
2,159
-3,166
-59% -$845K 0.32% 19
2020
Q1
$1.61M Hold
5,325
0.77% 15
2019
Q4
$1.61M Buy
5,325
+544
+11% +$150K 0.77% 15
2019
Q3
$1.15M Buy
4,781
+552
+13% +$151K 0.56% 17
2019
Q2
$1.19M Buy
4,229
+2,888
+215% +$789K 0.6% 16
2019
Q1
$385K Buy
+1,341
New +$388K 0.21% 43
2016
Q1
Sell
-9,063
Closed -$1.26M 33
2015
Q4
$1.26M Sell
9,063
-110
-1% -$15.2K 1.13% 13
2015
Q3
$1.28M Sell
9,173
-3
-0% -$451 1.15% 11
2015
Q2
$1.51M Buy
9,176
+29
+0.3% +$4.63K 1.25% 11
2015
Q1
$1.41M Sell
9,147
-20
-0.2% -$2.85K 1.19% 11
2014
Q4
$1.15M Buy
+9,167
New +$1.13M 1% 13

Other funds holding ELV

Biltmore Wealth Management's ELV Position: Q1 2021 in Review

Biltmore Wealth Management sold out of Elevance Health (ELV) in Q1 2021, closing a stake of 1,911 shares — an estimated $614K sold.

Biltmore Wealth Management first reported a position in ELV in Q4 2014 and held it in 13 quarters. The position peaked at $1.61M in Q1 2020. 1,211 funds tracked by Wall St. Rank hold ELV as of Q1 2021.

  • Biltmore Wealth Management reported no remaining Elevance Health position as of Q1 2021 after selling out during the quarter.
  • Biltmore Wealth Management sold 1,911 Elevance Health shares in Q1 2021, an estimated $614K.
  • Biltmore Wealth Management first reported a position in Elevance Health in Q4 2014 and held it in 13 quarters.
  • Biltmore Wealth Management's Elevance Health position peaked at $1.61M in Q1 2020.
  • 1,211 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.

Based on Biltmore Wealth Management's 13F filing for Q1 2021, filed 29 Apr 2021.